{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:52:21Z","timestamp":1789879941667,"version":"4.0.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.026","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T10:34:43Z","timestamp":1539081283000},"page":"6606-6614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["The Euvichol story \u2013 Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships"],"prefix":"10.1016","volume":"36","author":[{"given":"Lina","family":"Odevall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Digilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushant","family":"Sahastrabuddhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittal","family":"Mogasale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongok","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seukkeun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.026_b0005","unstructured":"WHO. Global immunization data. February 2014; 2014."},{"key":"10.1016\/j.vaccine.2018.09.026_b0010","unstructured":"Cholera vaccines: WHO position paper - August 2017. Wkly Epidemiol Rec. 2017; 92(34): p. 477\u201398."},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.026_b0020","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/cir141","article-title":"Oral vaccines against cholera","volume":"52","author":"Shin","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8684","key":"10.1016\/j.vaccine.2018.09.026_b0025","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"8932","key":"10.1016\/j.vaccine.2018.09.026_b0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(94)90755-2","article-title":"Protective efficacy of oral whole-cell\/recombinant-B-subunit cholera vaccine in Peruvian military recruits","volume":"344","author":"Sanchez","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.09.026_b0035","unstructured":"Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010; 85(13): p. 117\u201328."},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.026_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001712","article-title":"Oral cholera vaccine development and use in Vietnam","volume":"11","author":"Anh","year":"2014","journal-title":"PLoS Med"},{"issue":"9047","key":"10.1016\/j.vaccine.2018.09.026_b0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.026_b0050","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"9702","key":"10.1016\/j.vaccine.2018.09.026_b0065","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2018.09.026_b0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.026_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.026_b0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"New England J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0085","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine."},{"issue":"20","key":"10.1016\/j.vaccine.2018.09.026_b0090","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.vaccine.2006.03.008","article-title":"Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam","volume":"24","author":"Thiem","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.026_b0095","unstructured":"Cholera vaccines: WHO position paper. Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire 2010; 85(13): p. 117\u201328."},{"key":"10.1016\/j.vaccine.2018.09.026_b0100","unstructured":"WHO. WHO Consultation on oral cholera vaccine (OCV) stockpile strategic framework: potential objectives and possible policy options: 18-20 September 2011, Geneva, Switzerland; 2012."},{"key":"10.1016\/j.vaccine.2018.09.026_b0105","series-title":"An investment case for the accelerated introduction of oral cholera vaccines","author":"Levin","year":"2012"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.026_b0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea","volume":"29","author":"Baik","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"46","key":"10.1016\/j.vaccine.2018.09.026_b0115","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2015.08.075","article-title":"A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines","volume":"33","author":"Baik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.026_b0120","unstructured":"WHO. Out of cold chain (OCC) and Controlled Temperature Chain (CTC) use of vaccines. Immunization Practices Advisory Committee; 2017 [updated 2017; cited]; http:\/\/www.who.int\/immunization\/programmes_systems\/supply_chain\/ctc\/en\/."},{"key":"10.1016\/j.vaccine.2018.09.026_b0125","unstructured":"WHO. WHO Prequalified Vaccines [cited]; Available from: https:\/\/extranet.who.int\/gavi\/PQ_Web\/PreviewVaccine.aspx?nav=0&ID=249."},{"key":"10.1016\/j.vaccine.2018.09.026_b0130","series-title":"Perspectives from nonprofits on accelerating product development and improving access for low- and middle-income countries","author":"Global Health Technologies Coalition (GHTC): Developing Technologies to Address Poverty-Related and Neglected Disease and Conditions","year":"2013"},{"key":"10.1016\/j.vaccine.2018.09.026_b0135","unstructured":"Increasing Access to Vaccines Through Technology Transfer and Local Production: WHO; 2011."},{"issue":"46","key":"10.1016\/j.vaccine.2018.09.026_b0140","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1016\/j.vaccine.2011.08.108","article-title":"Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age","volume":"29","author":"Saha","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.026_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.026_b0150","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.13-0183","article-title":"Use of oral cholera vaccine in Haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013","journal-title":"Am J Trop Med Hygiene"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.026_b0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4269\/ajtmh.13-0171","article-title":"Cholera vaccination in urban Haiti","volume":"89","author":"Rouzier","year":"2013","journal-title":"Am J Trop Med Hygiene"},{"issue":"22","key":"10.1016\/j.vaccine.2018.09.026_b0160","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.026_b0165","article-title":"First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012","volume":"7","author":"Luquero","year":"2013","journal-title":"PLoS NeglTrop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.026_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001512","article-title":"Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea","volume":"10","author":"Ciglenecki","year":"2013","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.vaccine.2018.09.026_b0175","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/trstmh\/tru153","article-title":"Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan","volume":"108","author":"Porta","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.026_b0180","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vaccine.2015.10.112","article-title":"Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand","volume":"34","author":"Phares","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3201\/eid2106.141797","article-title":"Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, Haiti, 2013","volume":"21","author":"Tohme","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2018.09.026_b0190","first-page":"214","article-title":"Oral cholera vaccine campaign among internally displaced persons in South Sudan","volume":"89","author":"WHO","year":"2014","journal-title":"Weekly Epidemiological Record= Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire"},{"key":"10.1016\/j.vaccine.2018.09.026_b0195","first-page":"1","article-title":"Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia","author":"Teshome","year":"2018","journal-title":"Human Vaccines Immunotherapeut"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.026_b0200","article-title":"Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi","volume":"23","author":"Msyamboza","year":"2016","journal-title":"Pan African Med J"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.026_b0205","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4161\/21645515.2014.971655","article-title":"Uptake during an oral cholera vaccine pilot demonstration program, Odisha, India","volume":"10","author":"Kar","year":"2014","journal-title":"Human Vaccines Immunotherapeut"},{"issue":"21","key":"10.1016\/j.vaccine.2018.09.026_b0210","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.vaccine.2015.03.073","article-title":"Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India","volume":"33","author":"Wierzba","year":"2015","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.026_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004937","article-title":"Knowledge, attitudes, and practices regarding diarrhea and cholera following an oral cholera vaccination campaign in the solomon islands","volume":"10","author":"Burnett","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.026_b0220","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2471\/BLT.16.175166","article-title":"Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings","volume":"95","author":"Hsiao","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.09.026_b0225","unstructured":"WHO. Oral Cholera Vaccine. [cited]; Available from: http:\/\/www.who.int\/cholera\/vaccines\/en\/."},{"key":"10.1016\/j.vaccine.2018.09.026_b0230","unstructured":"The Global Task Force on Cholera Control. [cited]; Available from: http:\/\/www.who.int\/cholera\/task_force\/en\/."},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.026_b0235","article-title":"Cholera incidence and mortality in Sub-Saharan African sites during multi-country surveillance","volume":"10","author":"Sauvageot","year":"2016","journal-title":"PLoS NeglTrop Dis"},{"issue":"10133","key":"10.1016\/j.vaccine.2018.09.026_b0240","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(17)33050-7","article-title":"Mapping the burden of cholera in sub-Saharan Africa and implications for control: an analysis of data across geographical scales","volume":"391","author":"Lessler","year":"2018","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.026_b0245","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.026_b0250","doi-asserted-by":"crossref","first-page":"e1028","DOI":"10.1016\/S2214-109X(18)30284-5","article-title":"Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study","volume":"6","author":"Franke","year":"2018","journal-title":"Lancet Global Health"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.026_b0255","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Global Health"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0260","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S1473-3099(18)30108-7","article-title":"Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial","volume":"18","author":"Qadri","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.026_b0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJMc1711583","article-title":"Single-dose cholera vaccine in response to an outbreak in Zambia","volume":"378","author":"Ferreras","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.vaccine.2018.09.026_b0270","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa1510330","article-title":"Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh","volume":"374","author":"Qadri","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.026_b0275","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"Poncin","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.026_b0280","article-title":"Flexibility of oral cholera vaccine dosing\u2014a randomized controlled trial measuring immune responses following alternative vaccination schedules in a cholera hyper-endemic zone","volume":"9","author":"Kanungo","year":"2015","journal-title":"PLoS NeglTrop Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2018.09.026_b0285","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2017.07.104","article-title":"Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016","volume":"35","author":"Sauvageot","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.026_b0290","series-title":"An evaluation of GAVI Alliance efforts to introduce new vaccines via the Accelerated Development and Introduction Plans (ADIPs) and the Hib Initiative (HI)","author":"Milstien","year":"2007"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:28:24Z","timestamp":1759400904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":58,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312763"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.026","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Euvichol story \u2013 Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}